HCA - HCA Healthcare, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Nashville,
United States
Type: Equity
HCA price evolution
HCA
| (in millions $) | 1 May 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $935 | $891 | $862 | |
| Short term investments | ||||
| Net receivables | $9958 | $9182 | $8713 | |
| Inventory | $2021 | $2030 | $2050 | |
| Total current assets | $14927 | $14294 | $13888 | |
| Long term investments | $1233 | $1121 | $1115 | |
| Property, plant & equipment | $29922 | $29196 | $28754 | |
| Goodwill & intangible assets | $9945 | $9778 | $9641 | |
| Total noncurrent assets | $41284 | $40295 | $39706 | |
| Total investments | $1233 | $1121 | $1115 | |
| Total assets | $56211 | $54589 | $53594 | |
| Current liabilities | ||||
| Accounts payable | $4233 | $4139 | $3823 | |
| Deferred revenue | ||||
| Short long term debt | $2424 | $2553 | $2395 | |
| Total current liabilities | $12655 | $12407 | $11545 | |
| Long term debt | $37169 | $38569 | $38343 | |
| Total noncurrent liabilities | $42496 | $41825 | $41588 | |
| Total debt | $41496 | $41122 | $40738 | |
| Total liabilities | $57985 | $54232 | $53133 | |
| Shareholders' equity | ||||
| Retained earnings | -$1352 | -$1989 | -$1850 | |
| Other shareholder equity | -$1774 | -$491 | -$456 | |
| Total shareholder equity | -$1774 | -$2477 | -$2303 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $935 | $908 | $1451 | $1793 |
| Short term investments | $116 | |||
| Net receivables | $9958 | $8891 | $8095 | $7051 |
| Inventory | $2021 | $2068 | $1986 | $2025 |
| Total current assets | $14927 | $13643 | $13542 | $12333 |
| Long term investments | $1233 | $1204 | $886 | $810 |
| Property, plant & equipment | $29922 | $27640 | $26176 | $25223 |
| Goodwill & intangible assets | $9945 | $9653 | $9540 | $8578 |
| Total noncurrent assets | $41284 | $38795 | $37200 | $35157 |
| Total investments | $1233 | $1204 | $886 | $810 |
| Total assets | $56211 | $52438 | $50742 | $47490 |
| Current liabilities | ||||
| Accounts payable | $4233 | $4239 | $4111 | $3535 |
| Deferred revenue | ||||
| Short long term debt | $2424 | $370 | $237 | $209 |
| Total current liabilities | $12655 | $9902 | $9582 | $8704 |
| Long term debt | $37169 | $37714 | $36097 | $32468 |
| Total noncurrent liabilities | $42496 | $42609 | $39671 | $35894 |
| Total debt | $41496 | $39836 | $36334 | $32677 |
| Total liabilities | $57985 | $55205 | $49253 | $44598 |
| Shareholders' equity | ||||
| Retained earnings | -$1352 | -$2280 | -$532 | $777 |
| Other shareholder equity | -$1774 | -$2767 | -$404 | -$502 |
| Total shareholder equity | -$1774 | -$2767 | -$933 | $572 |
| (in millions $) | 1 May 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17303 | $16213 | $15861 | |
| Cost of revenue | $9973 | $9755 | ||
| Gross Profit | $14719 | $6240 | $6106 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $11918 | $4148 | $3806 | |
| Operating income | $2092 | $2300 | ||
| Income from continuing operations | ||||
| EBIT | $1917 | $2075 | ||
| Income tax expense | $484 | $355 | $397 | |
| Interest expense | -$463 | $483 | $485 | |
| Net income | ||||
| Net income | $1607 | $1079 | $1193 | |
| Income (for common shares) | $1079 | $1193 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $64968 | $60233 | $51533 | |
| Cost of revenue | $37056 | $32243 | ||
| Gross Profit | $55066 | $23177 | $19290 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $45439 | $14124 | $12028 | |
| Operating income | $9053 | $7262 | ||
| Income from continuing operations | ||||
| EBIT | $9130 | $6381 | ||
| Income tax expense | $1615 | $1746 | $1043 | |
| Interest expense | -$1916 | $1741 | $1584 | |
| Net income | ||||
| Net income | $5242 | $5643 | $3754 | |
| Income (for common shares) | $5643 | $3754 | ||
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $1079 | $1193 | $1363 | |
| Operating activities | ||||
| Depreciation | $769 | $763 | $756 | |
| Business acquisitions & disposals | -$146 | -$2 | $50 | |
| Stock-based compensation | $72 | $56 | $77 | |
| Total cash flows from operations | $2479 | $2475 | $1803 | |
| Investing activities | ||||
| Capital expenditures | -$1147 | -$1241 | -$1197 | |
| Investments | -$14 | -$3 | -$13 | |
| Total cash flows from investing | -$5317 | -$1312 | -$1257 | -$1151 |
| Financing activities | ||||
| Dividends paid | -$661 | -$162 | -$164 | -$175 |
| Sale and purchase of stock | -$1140 | -$915 | -$846 | |
| Net borrowings | $338 | $53 | $687 | |
| Total cash flows from financing | -$4094 | -$1132 | -$1198 | -$725 |
| Effect of exchange rate | $7 | -$6 | $7 | |
| Change in cash and equivalents | $27 | $29 | $20 | -$66 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $5643 | $6956 | $3754 | |
| Operating activities | ||||
| Depreciation | $2969 | $2853 | $2721 | |
| Business acquisitions & disposals | $1013 | $1055 | -$500 | |
| Stock-based compensation | $341 | $440 | $362 | |
| Total cash flows from operations | $8522 | $8959 | $9232 | |
| Investing activities | ||||
| Capital expenditures | -$4395 | -$3577 | -$2835 | |
| Investments | $14 | -$117 | -$20 | |
| Total cash flows from investing | -$5317 | -$3389 | -$2643 | -$3393 |
| Financing activities | ||||
| Dividends paid | -$661 | -$653 | -$624 | -$153 |
| Sale and purchase of stock | -$7000 | -$8215 | -$441 | |
| Net borrowings | $3234 | $3217 | -$3252 | |
| Total cash flows from financing | -$4094 | -$5656 | -$6655 | -$4677 |
| Effect of exchange rate | $7 | -$20 | -$3 | $10 |
| Change in cash and equivalents | $27 | -$543 | -$342 | $1172 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -32.69 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |